Senators question Allergan CEO on tribe patent deal

A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.

Allergan CEO on patent deal: 'It wasn't desperation, it was tenacity

How to Protect a Drug Patent? Give It to a Native American Tribe - The New York Times

Speaker Biographies and Faculty - Scope Summit

Allergan does patent deal for Restasis with Native American tribe

Allergan Patent Deal May Hurt Competition, Lawmakers Say - Bloomberg

Does Allergan's Saint Regis Mohawk Tribe transactional move rip off consumers? - The IPKat

CONTROVERSIAL STRATEGY: SELLING PATENTS TO A NATIVE AMERICAN TRIBE

Allergan Restasis Patents Invalid in Texas District Court

Ed Silverman - STAT - Page 218 of 299

Senators blast Allergan's tribal deal, social contract as 'hypocrisy

Senators blast Allergan's tribal deal, social contract as 'hypocrisy